Literature DB >> 8399412

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins.

M H Rapaport1, E F Torrey, C G McAllister, D L Nelson, D Pickar, S M Paul.   

Abstract

There is a confusing history of immune findings associated with schizophrenia. At least some of these discrepant results may be artifacts caused by heterogeneity. In an attempt to decrease heterogeneity, we studied three groups of monozygotic twins who were either discordant for schizophrenia, concordant and ill, or concordant and well. This comparison minimizes environmental and genetic variance, and heightens differences that are actually due to the disorder. Overall, schizophrenic subjects had higher levels of serum soluble interleukin-2 receptors (SIL-2Rs) than unaffected individuals (480.8, SD 238.6 U/ml vs 380.9, SD 170.6 U/ml; F = 5.256, df = 1.61, P = 0.02). When data from discordant and concordant twin groups were analysed separately, both the discordant ill twins (P = 0.06) and concordant ill twin pairs (P = 0.08) showed trends towards higher serum SIL-2R levels than their respective control groups. These data contribute to the growing body of evidence that immune activation is associated with some forms of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399412     DOI: 10.1007/bf02191517

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  16 in total

1.  Neuropsychological assessment of monozygotic twins discordant for schizophrenia.

Authors:  T E Goldberg; J D Ragland; E F Torrey; J M Gold; L B Bigelow; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1990-11

2.  Haloperidol and soluble interleukin-2 receptors.

Authors:  M H Rapaport; A R Doran; D L Nelson; C McAllister; J R Magliozzi; S M Paul
Journal:  Biol Psychiatry       Date:  1991-11-15       Impact factor: 13.382

3.  Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.

Authors:  C G McAllister; M H Rapaport; D Pickar; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1989-10

4.  Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects.

Authors:  R Ganguli; B S Rabin
Journal:  Arch Gen Psychiatry       Date:  1989-03

5.  Decreased production of interleukin-2 in schizophrenia.

Authors:  F Villemain; L Chatenoud; E Guillibert; Y Pelicier; J F Bach
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

6.  Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

Authors:  C G McAllister; M H Rapaport; D Pickar; T A Podruchny; G Christison; L D Alphs; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1989-10

Review 7.  The soluble interleukin-2 receptor: biology, function, and clinical application.

Authors:  L A Rubin; D L Nelson
Journal:  Ann Intern Med       Date:  1990-10-15       Impact factor: 25.391

8.  Morphometry of the corpus callosum in monozygotic twins discordant for schizophrenia: a magnetic resonance imaging study.

Authors:  M F Casanova; R D Sanders; T E Goldberg; L B Bigelow; G Christison; E F Torrey; D R Weinberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

9.  Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: a preliminary monozygotic twin study.

Authors:  H S Bracha; E F Torrey; L B Bigelow; J B Lohr; B B Linington
Journal:  Biol Psychiatry       Date:  1991-10-01       Impact factor: 13.382

10.  Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables.

Authors:  C Masserini; A Vita; R Basile; R Morselli; P Boato; C Peruzzi; L Pugnetti; P Ferrante; C L Cazzullo
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

View more
  8 in total

1.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

2.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 3.  Maternal infection and white matter toxicity.

Authors:  G Jean Harry; Cindy Lawler; Susan H Brunssen
Journal:  Neurotoxicology       Date:  2006-05-17       Impact factor: 4.294

4.  Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.

Authors:  N Müller; M Empl; M Riedel; M Schwarz; M Ackenheil
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 5.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.

Authors:  Mark H Rapaport; Catherine Bresee
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 7.  Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders.

Authors:  Somarani Dash; Yasir Ahmed Syed; Mojibur R Khan
Journal:  Front Cell Dev Biol       Date:  2022-04-14

Review 8.  IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.

Authors:  Ada Ng; Wilson W Tam; Melvyn W Zhang; Cyrus S Ho; Syeda F Husain; Roger S McIntyre; Roger C Ho
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.